about
Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosisDense deposit disease: clinicopathologic study of 32 pediatric and adult patientsDevelopment of focal segmental glomerulosclerosis after anabolic steroid abuseIgA nephropathy with minimal change disease.Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantationTenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.C1q nephropathy: a variant of focal segmental glomerulosclerosis.Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam.Nephrotic syndrome and ARF in a diabetic patient.Adult minimal-change disease: clinical characteristics, treatment, and outcomes.Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature.Immune complex glomerulonephritis in patients with hepatitis C.Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis.Proliferative glomerulonephritis with monoclonal IgG deposits.Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation.Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies.Morphologic variants of focal segmental glomerulosclerosis and their significance.Association between Reperfusion Renal Allograft Biopsy Findings and Transplant Outcomes.Delayed spontaneous resolution of nephrotic syndrome in a patient with hepatitis C virus-associated membranoproliferative glomerulonephritisPredictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohort.Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsImmune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus.ASN clinical pathological conference. Tenofovir-related ATN (severe).Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma.Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.BK polyoma virus nephropathy in the native kidney.A critically ill infant with sepsis, respiratory failure, and anasarca.Atypical Antiglomerular Basement Membrane Disease With IgG1-κ Staining.Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.Acute oxalate nephropathy due to ethylene glycol ingestion.The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.Full-house glomerular deposits: beware the sheep in wolf's clothing.Renal-limited 'lupus-like' nephritis.
P50
Q33195946-21A1D9D9-05EA-434C-8D0C-A35840B38649Q33338386-85B8CBA1-F47A-43D5-8479-0028EBC30E68Q33381183-20E334F2-FFEE-46B3-97DE-2483B1FF2B56Q33562274-7A5CDF5B-DBE9-4844-A45C-99293E7EF251Q33715857-8B2BD214-A643-4D74-B949-6422F8B46269Q33769962-EB5F401E-B9BA-4A41-BDE3-8BDF693157A3Q33827375-779F7DBF-E5A5-4AB3-8B4B-20B188C60DB6Q34135543-6FC85F72-30F4-4869-A163-A13C44B4D5ACQ34536880-2FBA7C4C-F010-459F-98C8-44A29E02890CQ34556944-B6F8CA4B-D720-491E-B4F2-F2260B018A4AQ35033818-5465E4CC-A553-49C5-B0DC-20C530C9320CQ35140906-D78DE141-90AB-4004-9D2B-6C89F987C7EBQ36910586-F834E22C-7896-4115-BAAD-5160D555C01FQ36947314-DF8E63D8-A1C4-4D01-A575-FC1753DE9CF9Q37060207-0CC6EDEF-04FD-433D-A445-FC016D036B8EQ37061812-C65C5422-AD24-4E78-AC9E-0E811B44F818Q37087861-E1EABD0D-B7B0-435E-BF85-98E13985BA15Q37330535-5E04FDA9-7710-4E0A-AD61-9D1BDFE301FEQ38173040-0FE729BF-D543-406B-B5B8-0E32E4DC9C98Q38226178-E123020A-8310-4510-BB52-FF7578E3785AQ38244351-CBCF1078-9037-43D5-B29F-2C2C5731AB78Q38690301-7FFCD394-C833-47EE-B7BA-07BAB56C7E57Q40332956-DE2E01CE-BDDA-46B1-824E-6A3D64A6BB5DQ40677285-8AC502A4-8DD3-473A-9EA6-1EAD59D2DF4CQ40775672-A4C099C5-6E36-433E-8C5D-8B51CEF08E7DQ41831841-D3B1FF7E-4A0F-426E-949F-10C963DD1AFBQ42982173-D5703986-DC27-4C3E-8A41-17A3861B5674Q44084474-2CBD1DDA-B58B-4F11-9FF2-1B6B0FB28FD3Q44198073-30F9B8CC-07D2-42EE-9B2C-8FE1B58E1BFCQ44846303-96C88147-559B-435E-AB6C-CCB763D51CF7Q45353437-C87CA8C9-8041-452B-AA43-D3D673577DE6Q45796518-D7B1F933-8E67-4037-96C2-B1D225067ED3Q45993000-5732CB61-3E2E-4405-888C-37C7D614CBBCQ46069563-98F022A0-8163-4F22-B200-F41E817DEE4CQ46311126-A03FA702-B964-4518-9AD8-094C5CC3C0AEQ46891049-B90CA8C9-9BAF-415D-B99E-144859868810Q47246603-90FC0888-C24B-4309-AE52-4C3ADD803422Q47989446-F55ACE64-5FE1-4288-AD68-98A83FD3638DQ48526180-945F7804-07FC-48F1-A904-C54A621D2357Q51372460-797915CB-6286-4DDD-96E6-CFD14F09B2B7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael B Stokes
@ast
Michael B Stokes
@en
Michael B Stokes
@es
Michael B Stokes
@nl
type
label
Michael B Stokes
@ast
Michael B Stokes
@en
Michael B Stokes
@es
Michael B Stokes
@nl
prefLabel
Michael B Stokes
@ast
Michael B Stokes
@en
Michael B Stokes
@es
Michael B Stokes
@nl
P106
P31
P496
0000-0003-0958-7672